Cogent Biosciences Inc (COGT) Stock Analysis

Cogent Biosciences Inc (COGT) is a publicly traded company in the HEALTHCARE sector. It trades at $32.76, carries a market capitalization of $5.97B. This page summarizes the public market data, fundamentals, and frequently asked questions for COGT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Cogent Biosciences Inc currently has a Bullish sentiment score of 0.37.

About Cogent Biosciences Inc

Cogent Biosciences, Inc. is an innovative biotechnology company located in Cambridge, Massachusetts, focused on developing precision therapies for genetically defined diseases. Utilizing its proprietary platform, Cogent aims to deliver targeted therapeutic solutions that address specific genetic mutations, significantly improving patient outcomes. With a robust pipeline and an emphasis on transformative treatments, the company is poised to become a key player in the precision medicine sector,...

GNG Research Analysis

GNG Research scores Cogent Biosciences Inc (COGT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for COGT.

Frequently Asked Questions

Does COGT pay dividends?

Cogent Biosciences Inc (COGT) does not currently pay a regular dividend.

What is COGT's market cap?

Cogent Biosciences Inc (COGT) has a market capitalization of $5.97B with a current stock price of $32.76.